Status:

COMPLETED

Evaluation of the EasySense System in Congestive Heart Failure

Lead Sponsor:

Ohio State University

Collaborating Sponsors:

National Institutes of Health (NIH)

University of Memphis

Conditions:

Congestive Heart Failure

Eligibility:

All Genders

21+ years

Brief Summary

The EasySense device is a non-invasive device designed to measure lung fluid in patients with Congestive Heart Failure (CHF). This study seeks to evaluate the efficacy of the EasySense system in measu...

Detailed Description

Across the globe, Congestive Heart Failure (CHF) continues to be the leading cause of mortality and hospitalizations in the 21st century. Despite advancements, prognosis often remains poor and mortali...

Eligibility Criteria

Inclusion

  • Current hospitalization for acute decompensated heart failure requiring IV diuretics or vasoactive drugs
  • NYHA class II-IV
  • Willing and able to participate in index and follow-up measurements
  • Able to speak, read, and write in English
  • Knows how to use a smartphone
  • Preference for patients who undergo a right heart catheterization or continuous pulmonary artery monitoring upon admission or during hospitalization

Exclusion

  • Current or planned treatments with any inotropic agents or mechanical support (LVAD, intra-aortic balloon pump, invasive mechanically assisted ventilation) at time of enrollment
  • Requiring demand pacing
  • Prior heart transplant
  • End-stage renal disease on hemodialysis
  • Physical deformities in the thorax area that may prevent proper application of EasySense device, as assessed by investigator
  • Sign of local rib cage or thoracic lesion or any illness which may be aggravated or cause significant discomfort from application of EasySense device, as assessed by investigator
  • Pregnancy or lactation

Key Trial Info

Start Date :

July 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 30 2020

Estimated Enrollment :

47 Patients enrolled

Trial Details

Trial ID

NCT03237923

Start Date

July 1 2017

End Date

June 30 2020

Last Update

February 5 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States, 43210